Literature DB >> 15082704

Lung cancer in US women: a contemporary epidemic.

Jyoti D Patel1, Peter B Bach, Mark G Kris.   

Abstract

Lung cancer is the leading cause of cancer death in US women and is responsible for as many deaths as breast cancer and all gynecological cancers combined. Most lung cancer is caused by cigarette smoke. Despite all that is known about the devastating effects of cigarettes, one quarter of women in the United States continue to smoke. Women are targeted in tobacco advertising, and teenage girls are often drawn to cigarette smoking under a variety of social pressures. Following the increase in smoking, the death rate from lung cancer in US women rose 600% from 1930 to 1997. Women may be more susceptible than men to the carcinogenic properties of cigarette smoke. In addition, differences in the biology of lung cancer exist between the 2 sexes with higher levels of DNA adduct formation, increased CYP1A1 expression, decreased DNA repair capacity, and increased incidence of K-ras gene mutations in women. The novel estrogen receptor beta has also been detected in lung tumors and suggests that estrogen signaling may have a biological role in tumorigenesis. Given these differences and given the enormous toll this disease has on US women, undertaking sex-specific research in lung cancer is crucial. Finally, disseminating information about this epidemic may prevent a similar epidemic in other parts of the world where women are just now becoming addicted to tobacco.

Entities:  

Mesh:

Year:  2004        PMID: 15082704     DOI: 10.1001/jama.291.14.1763

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  50 in total

1.  Targeting the estrogen pathway for the treatment and prevention of lung cancer.

Authors:  Timothy F Burns; Laura P Stabile
Journal:  Lung Cancer Manag       Date:  2014-02-01

2.  Estradiol and nicotine exposure enhances A549 bronchioloalveolar carcinoma xenograft growth in mice through the stimulation of angiogenesis.

Authors:  Michael J Jarzynka; Ping Guo; Ifat Bar-Joseph; Bo Hu; Shi-Yuan Cheng
Journal:  Int J Oncol       Date:  2006-02       Impact factor: 5.650

Review 3.  Lung cancer in never smokers: clinical epidemiology and environmental risk factors.

Authors:  Jonathan M Samet; Erika Avila-Tang; Paolo Boffetta; Lindsay M Hannan; Susan Olivo-Marston; Michael J Thun; Charles M Rudin
Journal:  Clin Cancer Res       Date:  2009-09-15       Impact factor: 12.531

Review 4.  It's all about sex: gender, lung development and lung disease.

Authors:  Michelle A Carey; Jeffrey W Card; James W Voltz; Samuel J Arbes; Dori R Germolec; Kenneth S Korach; Darryl C Zeldin
Journal:  Trends Endocrinol Metab       Date:  2007-08-30       Impact factor: 12.015

Review 5.  Epidemiology of lung cancer.

Authors:  Carole A Ridge; Aoife M McErlean; Michelle S Ginsberg
Journal:  Semin Intervent Radiol       Date:  2013-06       Impact factor: 1.513

6.  Impact of renal function on treatment options and outcomes in advanced non-small cell lung cancer.

Authors:  Bercin Kutluk Cenik; Han Sun; David E Gerber
Journal:  Lung Cancer       Date:  2013-03-15       Impact factor: 5.705

7.  Are women who smoke at higher risk for lung cancer than men who smoke?

Authors:  Sara De Matteis; Dario Consonni; Angela C Pesatori; Andrew W Bergen; Pier Alberto Bertazzi; Neil E Caporaso; Jay H Lubin; Sholom Wacholder; Maria Teresa Landi
Journal:  Am J Epidemiol       Date:  2013-02-20       Impact factor: 4.897

8.  Prognostic models to predict survival in non-small-cell lung cancer patients treated with first-line paclitaxel and carboplatin with or without bevacizumab.

Authors:  Tien Hoang; Suzanne E Dahlberg; Alan B Sandler; Julie R Brahmer; Joan H Schiller; David H Johnson
Journal:  J Thorac Oncol       Date:  2012-09       Impact factor: 15.609

9.  Lung cancer in women: histological type and patient age from 1985 to 2005.

Authors:  Jelena Stojsic; Ivan Milovanovic; Jelena Radojicic; Branislava Milenkovic
Journal:  Med Oncol       Date:  2008-11-04       Impact factor: 3.064

10.  Increase of hypophyseal hormone levels in male head and neck cancer patients.

Authors:  Eva Remenár; Irén Számel; Barna Budai; Borbála Vincze; István Gaudi; Sarolta Gundy; Miklós Kásler
Journal:  Pathol Oncol Res       Date:  2007-12-25       Impact factor: 3.201

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.